title: Leptin administration does not prevent the bone mineral metabolism changes induced by weight loss.
abstract: The objective was to examine the effects of weight loss and leptin administration following weight loss on calciotropic hormones and bone turnover. This was a prospective, single-blinded study of 12 subjects (8 women, 4 men; 2 nonobese, 10 obese; age range, 19-46 years) who were studied on an inpatient basis while maintaining their usual weight [Wt(initial)] and during maintenance of 10% weight loss while receiving twice-daily injections of either a placebo [Wt(-10%P)] or replacement doses of leptin [Wt(-10%L)]. The main outcome measures were markers of bone formation (bone alkaline phosphatase and procollagen type 1 amino terminal propeptide) and resorption (N-telopeptide) as well as parathyroid hormone, calcium, and 25-hydroxy vitamin D measured from fasting morning serum. As expected, serum leptin declined with weight loss. Bone alkaline phosphatase decreased by 12.3% ± 3.9% between Wt(initial) and Wt(-10%P) and remained suppressed after leptin administration (both P < .01 compared with baseline). N-telopeptides increased by 37.2% ± 11.3% from Wt(initial) to Wt(-10%L) (P < .01). Procollagen type 1 amino terminal propeptide, parathyroid hormone, calcium, and 25-hydroxy vitamin D did not change. These results suggest that both decreased bone formation and increased bone resorption underlie bone loss associated with weight loss. Leptin administration did not prevent the uncoupling of bone remodeling that accompanies weight loss.
authors.affiliation: Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.
authors.forename: Rushika
authors.initials: R
authors.lastname: Conroy
authors.forename: Monica
authors.initials: M
authors.lastname: Girotra
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Shane
authors.forename: Donald J
authors.initials: DJ
authors.lastname: McMahon
authors.forename: Katherine H
authors.initials: KH
authors.lastname: Pavlovich
authors.forename: Rudolph L
authors.initials: RL
authors.lastname: Leibel
authors.forename: Michael
authors.initials: M
authors.lastname: Rosenbaum
authors.forename: Judith
authors.initials: J
authors.lastname: Korner
mesh_terms: D000328:Adult; D016723:Bone Remodeling / Q000187:drug effects*; D024042:Collagen Type I / Q000097:blood; D018592:Cross-Over Studies; D005260:Female; D006801:Humans; D020738:Leptin / Q000097:blood / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000097:blood; D011446:Prospective Studies; D016037:Single-Blind Method; D014807:Vitamin D / Q000031:analogs & derivatives / Q000097:blood; D015431:Weight Loss / Q000502:physiology*
chemical_list: D024042:Collagen Type I; D020738:Leptin; D010455:Peptides; C052929:collagen type I trimeric cross-linked peptide; D014807:Vitamin D; C104450:25-hydroxyvitamin D